CYP2B6*6 genotype specific differences in artemether‐lumefantrine disposition in healthy volunteers

CYP2B6*6 genotype specific differences in artemether‐lumefantrine disposition in healthy volunteers

<p>Cytochrome P450 2B6 (CYP2B6) is involved in the metabolism of the antimalarial drugs artemether and lumefantrine. Here we investigated the effect of <em>CYP2B6</em>*6 on the plasma pharmacokinetics of artemether, lumefantrine, and their metabolites in healthy volunteers...

Полное описание

Библиографические подробности
Главные авторы:	Abdullahi, ST, Soyinka, JO, Olagunju, A, Bolarinwa, RA, Olarewaju, OJ, Bakare-Odunola, MT, Winterberg, M, Tarning, J, Owen, A, Khoo, S
Формат:	Journal article
Язык:	English
Опубликовано:	Wiley 2019

Схожие документы

Differential impact of nevirapine on artemether-lumefantrine pharmacokinetics in individuals stratified by CYP2B6 c.516G>T genotypes
по: Abdullahi, ST, и др.
Опубликовано: (2020)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
по: Ali, S, и др.
Опубликовано: (2010)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
по: Tarning Joel, и др.
Опубликовано: (2010-10-01)

Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine
по: Walimbwa, S, и др.
Опубликовано: (2018)

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
по: Sileshi Belew, и др.
Опубликовано: (2020-04-01)

Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.
по: German, P, и др.
Опубликовано: (2009)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
по: Tarning, J, и др.
Опубликовано: (2009)

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
по: Tarning, J, и др.
Опубликовано: (2022)

Artemether-lumefantrine coadministration with antiretrovirals; population pharmacokinetics and dosing implications.
по: Hoglund, R, и др.
Опубликовано: (2014)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
по: White, N, и др.
Опубликовано: (1999)

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
по: Joel Tarning, и др.
Опубликовано: (2022-10-01)

DRUG-DRUG INTERACTIONS BETWEEN ARTEMETHER/LUMEFANTRINE AND LOPINAVIR/RITONAVIR IN HIV NEGATIVE HEALTHY VOLUNTEERS
по: German, P, и др.
Опубликовано: (2008)

Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether‐lumefantrine for uncomplicated malaria
по: Chotsiri, P, и др.
Опубликовано: (2019)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
по: White, N, и др.
Опубликовано: (1999)

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
по: Peto, TJ, и др.
Опубликовано: (2022)

Quality Assessment of Artemether-Lumefantrine Samples and Artemether Injections Sold in the Cape Coast Metropolis
по: James Prah, и др.
Опубликовано: (2016-01-01)

Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults.
по: Byakika-Kibwika, P, и др.
Опубликовано: (2012)

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
по: van Vugt, M, и др.
Опубликовано: (1999)

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
по: van Vugt, M, и др.
Опубликовано: (2000)

Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria
по: Tchaparian, E, и др.
Опубликовано: (2016)

Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.
по: Byakika-Kibwika, P, и др.
Опубликовано: (2012)

Effectiveness of a 6-dose regimen of Artemether-Lumefantrine for unsupervised treatment of uncomplicated childhood malaria in Calabar, Nigeria
по: Meremikwu M, и др.
Опубликовано: (2024-07-01)

Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
по: Mwesigwa, J, и др.
Опубликовано: (2010)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
по: Mcgready, R, и др.
Опубликовано: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
по: McGready, R, и др.
Опубликовано: (2009)

Artemether/Lumefantrine for the Treatment of P. malariae in a Patient on Hemodialysis
по: Rita Patrocínio-Jesus, и др.
Опубликовано: (2019-01-01)

Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
по: Moses Ocan, и др.
Опубликовано: (2023-05-01)

Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
по: Wongani Nyangulu, и др.
Опубликовано: (2023-01-01)

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India
по: Dev Vas, и др.
Опубликовано: (2009-05-01)

The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.
по: Quique Bassat
Опубликовано: (2011-12-01)

Adverse reaction to Coartem (artemether/lumefantrine) resulting in oculogyric crisis
по: Emmanuel Kofi Amponsah, и др.
Опубликовано: (2021-05-01)

Population pharmacokinetics of artemether, dihydroartemisinin and lumefantrine in Rwandese pregnant women treated for uncomplicated Plasmodium falciparum malaria
по: Das, J, и др.
Опубликовано: (2018)

Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
по: Tarning, J, и др.
Опубликовано: (2013)

Antimalarial resistance unlikely to explain U.K. artemether-lumefantrine failures
по: van der Pluijm, R, и др.
Опубликовано: (2017)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
по: Denis, M, и др.
Опубликовано: (2006)

Genomic characterization of recrudescent plasmodium malariae after treatment with artemether/lumefantrine
по: Rutledge, G, и др.
Опубликовано: (2017)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.
по: Sipilanyambe, N, и др.
Опубликовано: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
по: Sipilanyambe, N, и др.
Опубликовано: (2008)

A case-control auditory evaluation of patients treated with artemether-lumefantrine.
по: Hutagalung, R, и др.
Опубликовано: (2006)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
по: Zurovac, D, и др.
Опубликовано: (2008)